Tag: Paul Kim
Simpson, Nishimura act on USD2.1bn Japan pharma buyout
Simpson Thacher & Bartlett and Nishimura & Asahi are advising on the USD2.1 billion acquisition of Alinamin
Simpson Thacher & Bartlett and Nishimura & Asahi are advising on the USD2.1 billion acquisition of Alinamin
An unprecedented transfer of private wealth is colliding with tighter regulation and rising complexity